| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 358 | 301 | +18.8% |
| EBITDA | 15.4 | 16.8 | −8.5% |
| EBITDA margin | 4.3% | 5.6% | −1.3 pts |
| Profit before tax | 10.8 | 9.3 | +15.8% |
| Net profit | 8.2 | 7.0 | +17.0% |
| EPS | ₹0.07 | ₹0.07 | 0.0% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 |
|---|
| 437 | — | — | — | — | |
| 5.1 | 5.1 | 1.3 | 0.3 | 0.2 | |
| 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | |
| 251 | 251 | 303 | 297 | 287 | |
| 683 | — | — | — | — | |
| 1,402 | 1,346 | 1,136 | 870 | 689 | |
| — | +18.4% | +30.7% | +26.2% | — | |
| 64.7 | 66.1 | 71.8 | 55.8 | 32.5 | |
| 4.6% | 4.9% | 6.3% | 6.4% | 4.7% | |
| 63.1 | 64.6 | 70.7 | 54.7 | 29.7 | |
| 33.0 | 31.8 | 26.9 | 16.8 | 7.8 | |
| 2.4% | 2.4% | 2.4% | 1.9% | 1.1% | |
| ₹0.27 | ₹0.26 | ₹0.22 | ₹0.14 | ₹0.06 | |
| — | +17.2% | +61.7% | +115.2% | — | |
| — | −61.1 | 14.7 | −9.2 | −35.7 | |
| — | −1.1 | −1.3 | −0.7 | −0.2 | |
| −62.2 | −62.2 | 13.4 | −9.8 | −36.0 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 437.2 | |
| - Cash, Equiv & ST Investments | 0.2 | 0.3 | 1.3 | 5.1 | 5.1 | |
| + Minority Interest | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | |
| + Total Debt | 287.0 | 297.3 | 302.8 | 250.6 | 250.6 | |
| Enterprise Value | — | — | — | — | 683.1 | |
| Revenue | 689.3 | 869.6 | 1,136.2 | 1,345.6 | 1,402.3 | |
| Growth %, YoY | — | +26.2 | +30.7 | +18.4 | — | |
| EBITDA | 32.5 | 55.8 | 71.8 | 66.1 | 64.7 | |
| Margin % | 4.71 | 6.42 | 6.32 | 4.91 | 4.61 | |
| EBIT | 29.7 | 54.7 | 70.7 | 64.6 | 63.1 | |
| Net Income | 7.8 | 16.8 | 26.9 | 31.8 | 33.0 | |
| Margin % | 1.13 | 1.93 | 2.37 | 2.36 | 2.35 | |
| EPS, Adj (current shares) | 0.06 | 0.14 | 0.22 | 0.26 | 0.27 | |
| Growth %, YoY | — | +115.2 | +61.7 | +17.2 | — | |
| Cash from Operations | -35.7 | -9.2 | 14.7 | -61.1 | — | |
| Capital Expenditures | -0.2 | -0.7 | -1.3 | -1.1 | — | |
| Free Cash Flow | -36.0 | -9.8 | 13.4 | -62.2 | -62.2 | |
Prices at the previous close · figures from the company's filings with NSE
Sarveshwar Foods (NSE: SARVESHWAR) had a market capitalisation of ₹437 crore at the previous close (₹3.55 a share), a PE ratio of 13.2 on the last four quarters' profit and a price-to-book ratio of 0.92. In FY26 its consolidated net profit was ₹31.8 crore on revenue of ₹1,346 crore; in Q1 FY27 (April–June 2026) it was ₹8.2 crore, up 17.0% year on year. Its debt-to-equity ratio was 0.52 on 31 March 2026. Promoters held 40.87% of the shares on 30 September 2026.
Sarveshwar Foods' PE ratio is 13.2 at the previous close (₹3.55 a share): a market capitalisation of ₹437 crore divided by consolidated net profit of ₹33.1 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹31.8 crore) it is 13.8.
Sarveshwar Foods' debt-to-equity ratio was 0.52 on 31 March 2026: borrowings of ₹251 crore against total equity of ₹478 crore. A year earlier, on 31 March 2025, it was 0.99.
Sarveshwar Foods' net worth — shareholders' equity in its consolidated balance sheet — was ₹477 crore on 31 March 2026, up 56.8% from ₹304 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹437 crore at the previous close.
Sarveshwar Foods' price-to-book (PB) ratio is 0.92 at the previous close: a market capitalisation of ₹437 crore divided by shareholders' equity (book value) of ₹477 crore on 31 March 2026. That is a book value of ₹3.87 per share against a share price of ₹3.55.
In FY26, Sarveshwar Foods' return on equity (ROE) was 8.1% and its return on capital employed (ROCE) was 16.1%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 9.7% and ROCE 21.3%.
Sarveshwar Foods' book value per share was ₹3.87 on 31 March 2026: shareholders' equity of ₹477 crore divided by the 123.16 crore shares in issue. The share price at the previous close was ₹3.55.
Sarveshwar Foods' market capitalisation was ₹437 crore at the previous close: 123.16 crore shares at ₹3.55 each.
No. Sarveshwar Foods had borrowings of ₹251 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.52. Its cash and current investments were ₹5.1 crore, so its net debt was ₹246 crore.
Sarveshwar Foods' basic earnings per share (EPS) were ₹0.29 in FY26, against ₹0.28 in FY25.
Promoters held 40.87% of Sarveshwar Foods on 30 September 2026, unchanged from the previous quarter and down 0.10 percentage points from 40.97% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Sarveshwar Foods generated ₹61.1 crore of cash from operations and spent ₹1.1 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹62.2 crore. In FY25 it was ₹13.4 crore.
Sarveshwar Foods has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
On 30 September 2026, Sarveshwar Foods' shares were held by promoters 40.87%, foreign portfolio investors (FII/FPI) 0.25%, domestic institutions (DII) 0.02% (including mutual funds at 0.00%) and retail and other non-institutional investors 58.86%. Over the year, FII holding was up 0.02 percentage points from 0.23% and DII holding was down 0.14 percentage points from 0.16%.
On FY26 consolidated figures, against Sukhjit Starch & Chemicals, Nath Bio-Genes and Indo Us Biotech: Sarveshwar Foods' operating margin of 4.8% is the third highest of the four (Sukhjit Starch & Chemicals 3.4%, Nath Bio-Genes 10.9%, Indo Us Biotech 14.6%; peer average 9.6%); its return on equity of 8.1% is the second highest of the four (Sukhjit Starch & Chemicals 4.9%, Nath Bio-Genes 6.3%, Indo Us Biotech 15.3%; peer average 8.8%).
In FY26, Sarveshwar Foods earned net profit of ₹31.8 crore on revenue of ₹1,346 crore, against ₹27 crore on ₹1,432 crore for Sukhjit Starch & Chemicals. Sarveshwar Foods' operating margin was 4.8% (Sukhjit Starch & Chemicals 3.4%) and its return on equity 8.1% (Sukhjit Starch & Chemicals 4.9%).
Sarveshwar Foods' latest results are for Q1 FY27 (April–June 2026), filed on 31 July 2026: consolidated net profit ₹8.2 crore, up 17.0% from ₹7 crore in Q1 FY26; revenue from operations ₹358 crore, up 18.8% year on year.
In FY26 (April 2025–March 2026), Sarveshwar Foods' consolidated net profit was ₹31.8 crore, up 17.2% from ₹27.1 crore in FY25, on revenue from operations of ₹1,346 crore (up 18.4%). Over three years, from FY23, net profit was up 308.1%.
From Sarveshwar Foods' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.